• Report Description
  • Table Of Content
  • Request Methodology

Global anti-infective drugs market is estimated to reach USD 169.5 Billion in 2024, registering a compound annual growth rate (CAGR) of 4.1% between 2019 and 2024. Growing number of anti-infection treatment and procedures is one of the key factors which is driving the growth of global anti-infective drugs market.

Market Insights

Growth Drivers – Anti-infective Drugs Market

Rising Penetration of Infectious Diseases

Increasing prevalence of infectious disease such as malaria, HIV, Ebola among others is expected to foster the growth of global anti-infective drugs market during the forecast period. Additionally, increasing awareness about infectious disease among people is believed to positively impact the growth of global anti-infective drugs market.

Favorable government initiatives such as awareness campaigns and reimbursement policies are also expanding the scope of growth of market players. Moreover, various companies are actively engaged in advanced drug discovery. This factor is envisioned to bolster the growth of market.

Development of New Drugs

Continuous development and innovation of new drugs is anticipated to drive the growth of global anti-infective drugs market. Some companies with Phase 3 trials such as Iterum Therapeutics, Spero Therapeutics, Nabriva Therapeutics, and Tetraphase Pharmaceuticals are likely to get approval within 12 months. This will also lead to growth of global anti-infective drugs market.

Get a brochure of this research study Click Here

Barriers – Anti-infective Drugs Market

Anti-infective Drugs Shortages

Transient shortage and long-terms shortage of anti-infective drugs is a major growth barrier in the global anti-infective drugs market. Apart from this, various major manufacturers are shutting down their antibiotic research and development which is further likely to negative impact the growth of global anti-infective drugs market.

Segmentation Analysis

The anti-infective drugs market by product type is segmented into anti-bacterial drugs, anti-fungal drugs, and anti-viral drugs. In this segment, anti-viral drugs segment is anticipated to capture the largest market share in 2024.

Based on indication, the anti-infective drugs market is further sub segmented into pneumonia, methicillin-resistant staphylococcus aureus, sepsis, tuberculosis, dermatophytosis, aspergillosis, candidiasis, hepatitis virus infection, HIV infection and respiratory virus infection. HIV captured significant market share in overall anti-infective drugs market in 2018.

Geographical Analysis

Geographically, the report offers analysis of North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In anti-infective drugs market, North America dominated in 2018, acquiring significant portion of overall market. Factors such as increasing geriatric population and presence of advanced healthcare infrastructure are some of the major factors which are believed to bolster the growth of anti-infective drugs formula in North America. Asia Pacific anti-infective drugs market is expected to showcase highest growth rate during the forecast period. Presence of generic companies and increasing spending on healthcare is anticipated to positively impact the demand for Asia Pacific anti-infective drugs market.

Competitive Analysis

The report also covers detailed competitive analysis of major market players of global anti-infective drugs market, such as Gilead Sciences, GlaxoSmithKline plc, Merck & Co, Teva Pharmaceutical Industries Ltd., Johnson & Johnson, Boehringer Ingelheim GmbH, Pfizer, Mylan N.V., Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd and other prominent players. The anti-infective drugs market is witnessing a wide range of industry activities such as product launch, acquisition, partnership, and expansion across the globe.

Segmentation

By Product Type
- Anti-bacterial Drugs
      - B-lactams
      - Quinolones
      - Macrolides
      - Tetracycline
      - Aminoglycoside
      - Others
- Anti-fungal Drugs
      - Azoles
      - Echinocandins
      - Polyenes
- Anti-viral Drugs

By Indication
- Pneumonia
- Methicillin-resistant Staphylococcus Aureus (MRSA)
- Sepsis
- Tuberculosis
- Dermatophytosis
- Aspergillosis
- Candidiasis
- Hepatitis Virus Infection
- HIV Infection
- Respiratory Virus Infection

By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Sales

By Geography:
- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New Zealand and Rest of Asia Pacific)
- Latin America (Brazil, Mexico, Argentina and Rest of Latin America)
- Middle East & Africa (GCC, North Africa, South Africa and Rest of Middle East & Africa)

Competitive Landscape

The report profiles various major market players such as
- Gilead Sciences
- GlaxoSmithKline plc
- Merck & Co
- Teva Pharmaceutical Industries Ltd.
- Johnson & Johnson
- Boehringer Ingelheim GmbH
- Pfizer
- Mylan N.V.
- Bristol-Myers Squibb
- F. Hoffmann-La Roche Ltd
- Other Prominent Players

Competitive landscape analysis provides detailed strategic analysis of the company’s business and performance such as financial information, revenue breakup by segment and by geography, SWOT Analysis, key facts, company overview, business strategy, key product offerings, marketing and distribution strategies, new product development, recent news (acquisition, expansion, technology development, research & development and other market activities).

The study also provides company’s positioning and market share in anti-infective drugs market.

Timeline Considered for Analysis:
- 2018: Base Year
- 2019: Estimated Year
- 2019 to 2024: Forecast Period

Research Scope and Deliverables
Overview & Executive Summary
Market Drivers, Trends, Challenges and Opportunities
Market Size and Forecast Projections
Macroeconomic Indicators of Various Countries Impacting the Growth of the Market
Extensive Coverage of Industry Players including Recent Product Launches and Market Activities
Porter’s Five Force Analysis

Market Segmentation Analysis:
Industry report analyzes the global anti-infective drugs market by the following segments:
- Product Type
- Indication
- Distribution Channel

Customization: We also offers customization’s in the industry report as per the company’s specific needs.

Key Questions Answered in the Global Anti-infective Drugs Industry Report

- What is the overall market size in 2018? What will be the market growth during the forecast period i.e. 2019-2024?
- Which region would have high demand for product in the upcoming years?
- What are the factors driving the growth of the market?
- Which sub-market will make the most significant contribution to the market?
- What are the market opportunities for existing and entry-level players?
- What are various long-term and short-term strategies adopted by the market players?

1. Preface
1.1. Research Methodology
1.2. Geographic Scope
1.3. Years Considered

2. Executive Summary

3. Market Overview
3.1. Anti-infective Drugs Overview
3.2. Market Definition & Key Market Segments
3.3. Industry Development
3.4. Global Market Maturity
3.4.1. North America
3.4.2. Europe
3.4.3. Asia Pacific
3.4.4. Latin America
3.4.5. Middle East & Africa
3.5. Porter’s Five Force Analysis
3.6. Industry Value Chain Analysis
3.7. Macro-Economic Trends

4. Competitive Landscape
4.1. Global Anti-infective Drugs Market 2018
4.2. Global Anti-infective Drugs Market Value Share, By Company 2018

5. Growth Drivers & Barriers in Global Anti-infective Drugs Market
5.1. North America
5.2. Europe
5.3. Asia Pacific
5.4. Rest of World

6. Trends in Global Anti-infective Drugs Market
6.1. North America
6.2. Europe
6.3. Asia Pacific
6.4. Rest of World

7. Global Anti-infective Drugs Market
7.1. Introduction
7.2. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

8. Global Anti-infective Drugs Market Segmentation Analysis, By Product Type
8.1. Introduction
8.2. Strategic Insights
8.2.1. BPS Analysis, By Product Type
8.2.2. Market Attractiveness, By Product Type
8.3. Anti-bacterial Drugs
8.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
8.3.2. B-lactams
8.3.2.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
8.3.3. Quinolones
8.3.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
8.3.4. Macrolides
8.3.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
8.3.5. Tetracycline
8.3.5.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
8.3.6. Aminoglycoside
8.3.6.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
8.3.7. Others
8.3.7.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
8.4. Anti-fungal Drugs
8.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
8.4.2. Azoles
8.4.2.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
8.4.3. Echinocandins
8.4.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
8.4.4. Polyenes
8.4.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
8.5. Anti-viral Drugs
8.5.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

9. Global Anti-infective Drugs Market Segmentation Analysis, By Indication
9.1. Introduction
9.2. Strategic Insights
9.2.1. BPS Analysis, By Indication
9.2.2. Market Attractiveness, By Indication
9.3. Pneumonia
9.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
9.4. Methicillin-resistant Staphylococcus Aureus (MRSA)
9.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
9.5. Sepsis
9.5.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
9.6. Tuberculosis
9.6.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
9.7. Dermatophytosis
9.7.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
9.8. Aspergillosis
9.8.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
9.9. Candidiasis
9.9.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
9.10. Hepatitis Virus Infection
9.10.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
9.11. HIV Infection
9.11.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
9.12. Respiratory Virus Infection
9.12.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

10. Global Anti-infective Drugs Market Segmentation Analysis, By Distribution Channel
10.1. Introduction
10.2. Strategic Insights
10.2.1. BPS Analysis, By Distribution Channel
10.2.2. Market Attractiveness, By Distribution Channel
10.3. Hospital Pharmacy
10.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
10.4. Retail Pharmacy
10.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
10.5. Online Sales
10.5.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

11. Geographical Analysis
11.1. Introduction
11.2. North America Anti-infective Drugs Market
11.2.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.2.2. By Product Type
11.2.2.1. Introduction
11.2.2.2. Strategic Insights
11.2.2.2.1. BPS Analysis, By Product Type
11.2.2.2.2. Market Attractiveness, By Product Type
11.2.2.3. Anti-bacterial Drugs
11.2.2.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.2.2.3.2. B-lactams
11.2.2.3.2.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.2.2.3.3. Quinolones
11.2.2.3.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.2.2.3.4. Macrolides
11.2.2.3.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.2.2.3.5. Tetracycline
11.2.2.3.5.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.2.2.3.6. Aminoglycoside
11.2.2.3.6.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.2.2.3.7. Others
11.2.2.3.7.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.2.2.4. Anti-fungal Drugs
11.2.2.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.2.2.4.2. Azoles
11.2.2.4.2.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.2.2.4.3. Echinocandins
11.2.2.4.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.2.2.4.4. Polyenes
11.2.2.4.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.2.2.5. Anti-viral Drugs
11.2.2.5.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.2.3. By Indication
11.2.3.1. Introduction
11.2.3.2. Strategic Insights
11.2.3.2.1. BPS Analysis, By Indication
11.2.3.2.2. Market Attractiveness, By Indication
11.2.3.3. Pneumonia
11.2.3.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.2.3.4. Methicillin-resistant Staphylococcus Aureus (MRSA)
11.2.3.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.2.3.5. Sepsis
11.2.3.5.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.2.3.6. Tuberculosis
11.2.3.6.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.2.3.7. Dermatophytosis
11.2.3.7.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.2.3.8. Aspergillosis
11.2.3.8.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.2.3.9. Candidiasis
11.2.3.9.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.2.3.10. Hepatitis Virus Infection
11.2.3.10.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.2.3.11. HIV Infection
11.2.3.11.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.2.3.12. Respiratory Virus Infection
11.2.3.12.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.2.4. By Distribution Channel
11.2.4.1. Introduction
11.2.4.2. Strategic Insights
11.2.4.2.1. BPS Analysis, By Distribution Channel
11.2.4.2.2. Market Attractiveness, By Distribution Channel
11.2.4.3. Hospital Pharmacy
11.2.4.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.2.4.4. Retail Pharmacy
11.2.4.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.2.4.5. Online Sales
11.2.4.5.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.2.5. By Country
11.2.5.1. Introduction
11.2.5.2. Strategic Insights
11.2.5.2.1. BPS Analysis, By Country
11.2.5.2.2. Market Attractiveness, By Country
11.2.5.3. U.S. Anti-infective Drugs Market
11.2.5.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.2.5.4. Canada Anti-infective Drugs Market
11.2.5.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

11.3. Europe Anti-infective Drugs Market
11.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.3.2. By Product Type
11.3.2.1. Introduction
11.3.2.2. Strategic Insights
11.3.2.2.1. BPS Analysis, By Product Type
11.3.2.2.2. Market Attractiveness, By Product Type
11.3.2.3. Anti-bacterial Drugs
11.3.2.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.3.2.3.2. B-lactams
11.3.2.3.2.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.3.2.3.3. Quinolones
11.3.2.3.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.3.2.3.4. Macrolides
11.3.2.3.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.3.2.3.5. Tetracycline
11.3.2.3.5.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.3.2.3.6. Aminoglycoside
11.3.2.3.6.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.3.2.3.7. Others
11.3.2.3.7.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.3.2.4. Anti-fungal Drugs
11.3.2.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.3.2.4.2. Azoles
11.3.2.4.2.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.3.2.4.3. Echinocandins
11.3.2.4.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.3.2.4.4. Polyenes
11.3.2.4.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.3.2.5. Anti-viral Drugs
11.3.2.5.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.3.3. By Indication
11.3.3.1. Introduction
11.3.3.2. Strategic Insights
11.3.3.2.1. BPS Analysis, By Indication
11.3.3.2.2. Market Attractiveness, By Indication
11.3.3.3. Pneumonia
11.3.3.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.3.3.4. Methicillin-resistant Staphylococcus Aureus (MRSA)
11.3.3.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.3.3.5. Sepsis
11.3.3.5.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.3.3.6. Tuberculosis
11.3.3.6.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.3.3.7. Dermatophytosis
11.3.3.7.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.3.3.8. Aspergillosis
11.3.3.8.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.3.3.9. Candidiasis
11.3.3.9.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.3.3.10. Hepatitis Virus Infection
11.3.3.10.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.3.3.11. HIV Infection
11.3.3.11.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.3.3.12. Respiratory Virus Infection
11.3.3.12.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.3.4. By Distribution Channel
11.3.4.1. Introduction
11.3.4.2. Strategic Insights
11.3.4.2.1. BPS Analysis, By Distribution Channel
11.3.4.2.2. Market Attractiveness, By Distribution Channel
11.3.4.3. Hospital Pharmacy
11.3.4.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.3.4.4. Retail Pharmacy
11.3.4.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.3.4.5. Online Sales
11.3.4.5.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.3.5. By Country
11.3.5.1. Introduction
11.3.5.2. Strategic Insights
11.3.5.2.1. BPS Analysis, By Country
11.3.5.2.2. Market Attractiveness, By Country
11.3.5.3. Germany Anti-infective Drugs Market
11.3.5.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.3.5.4. United Kingdom Anti-infective Drugs Market
11.3.5.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.3.5.5. France Anti-infective Drugs Market
11.3.5.5.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.3.5.6. Italy Anti-infective Drugs Market
11.3.5.6.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.3.5.7. Spain Anti-infective Drugs Market
11.3.5.7.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.3.5.8. Russia Anti-infective Drugs Market
11.3.5.8.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.3.5.9. Rest of Europe Anti-infective Drugs Market
11.3.5.9.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

11.4. Asia Pacific Anti-infective Drugs Market
11.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.4.2. By Product Type
11.4.2.1. Introduction
11.4.2.2. Strategic Insights
11.4.2.2.1. BPS Analysis, By Product Type
11.4.2.2.2. Market Attractiveness, By Product Type
11.4.2.3. Anti-bacterial Drugs
11.4.2.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.4.2.3.2. B-lactams
11.4.2.3.2.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.4.2.3.3. Quinolones
11.4.2.3.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.4.2.3.4. Macrolides
11.4.2.3.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.4.2.3.5. Tetracycline
11.4.2.3.5.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.4.2.3.6. Aminoglycoside
11.4.2.3.6.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.4.2.3.7. Others
11.4.2.3.7.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.4.2.4. Anti-fungal Drugs
11.4.2.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.4.2.4.2. Azoles
11.4.2.4.2.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.4.2.4.3. Echinocandins
11.4.2.4.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.4.2.4.4. Polyenes
11.4.2.4.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.4.2.5. Anti-viral Drugs
11.4.2.5.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.4.3. By Indication
11.4.3.1. Introduction
11.4.3.2. Strategic Insights
11.4.3.2.1. BPS Analysis, By Indication
11.4.3.2.2. Market Attractiveness, By Indication
11.4.3.3. Pneumonia
11.4.3.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.4.3.4. Methicillin-resistant Staphylococcus Aureus (MRSA)
11.4.3.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.4.3.5. Sepsis
11.4.3.5.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.4.3.6. Tuberculosis
11.4.3.6.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.4.3.7. Dermatophytosis
11.4.3.7.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.4.3.8. Aspergillosis
11.4.3.8.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.4.3.9. Candidiasis
11.4.3.9.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.4.3.10. Hepatitis Virus Infection
11.4.3.10.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.4.3.11. HIV Infection
11.4.3.11.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.4.3.12. Respiratory Virus Infection
11.4.3.12.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.4.4. By Distribution Channel
11.4.4.1. Introduction
11.4.4.2. Strategic Insights
11.4.4.2.1. BPS Analysis, By Distribution Channel
11.4.4.2.2. Market Attractiveness, By Distribution Channel
11.4.4.3. Hospital Pharmacy
11.4.4.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.4.4.4. Retail Pharmacy
11.4.4.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.4.4.5. Online Sales
11.4.4.5.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.4.5. By Country
11.4.5.1. Introduction
11.4.5.2. Strategic Insights
11.4.5.2.1. BPS Analysis, By Country
11.4.5.2.2. Market Attractiveness, By Country
11.4.5.3. China Anti-infective Drugs Market
11.4.5.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.4.5.4. India Anti-infective Drugs Market
11.4.5.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.4.5.5. Japan Anti-infective Drugs Market
11.4.5.5.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.4.5.6. South Korea Anti-infective Drugs Market
11.4.5.6.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.4.5.7. Indonesia Anti-infective Drugs Market
11.4.5.7.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.4.5.8. Taiwan Anti-infective Drugs Market
11.4.5.8.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.4.5.9. Australia Anti-infective Drugs Market
11.4.5.9.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.4.5.10. New Zealand Anti-infective Drugs Market
11.4.5.10.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.4.5.11. Rest of Asia Pacific Anti-infective Drugs Market
11.4.5.11.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

11.5. Latin America Anti-infective Drugs Market
11.5.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.5.2. By Product Type
11.5.2.1. Introduction
11.5.2.2. Strategic Insights
11.5.2.2.1. BPS Analysis, By Product Type
11.5.2.2.2. Market Attractiveness, By Product Type
11.5.2.3. Anti-bacterial Drugs
11.5.2.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.5.2.3.2. B-lactams
11.5.2.3.2.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.5.2.3.3. Quinolones
11.5.2.3.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.5.2.3.4. Macrolides
11.5.2.3.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.5.2.3.5. Tetracycline
11.5.2.3.5.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.5.2.3.6. Aminoglycoside
11.5.2.3.6.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.5.2.3.7. Others
11.5.2.3.7.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.5.2.4. Anti-fungal Drugs
11.5.2.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.5.2.4.2. Azoles
11.5.2.4.2.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.5.2.4.3. Echinocandins
11.5.2.4.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.5.2.4.4. Polyenes
11.5.2.4.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.5.2.5. Anti-viral Drugs
11.5.2.5.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.5.3. By Indication
11.5.3.1. Introduction
11.5.3.2. Strategic Insights
11.5.3.2.1. BPS Analysis, By Indication
11.5.3.2.2. Market Attractiveness, By Indication
11.5.3.3. Pneumonia
11.5.3.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.5.3.4. Methicillin-resistant Staphylococcus Aureus (MRSA)
11.5.3.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.5.3.5. Sepsis
11.5.3.5.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.5.3.6. Tuberculosis
11.5.3.6.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.5.3.7. Dermatophytosis
11.5.3.7.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.5.3.8. Aspergillosis
11.5.3.8.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.5.3.9. Candidiasis
11.5.3.9.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.5.3.10. Hepatitis Virus Infection
11.5.3.10.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.5.3.11. HIV Infection
11.5.3.11.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.5.3.12. Respiratory Virus Infection
11.5.3.12.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.5.4. By Distribution Channel
11.5.4.1. Introduction
11.5.4.2. Strategic Insights
11.5.4.2.1. BPS Analysis, By Distribution Channel
11.5.4.2.2. Market Attractiveness, By Distribution Channel
11.5.4.3. Hospital Pharmacy
11.5.4.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.5.4.4. Retail Pharmacy
11.5.4.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.5.4.5. Online Sales
11.5.4.5.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.5.5. By Country
11.5.5.1. Introduction
11.5.5.2. Strategic Insights
11.5.5.2.1. BPS Analysis, By Country
11.5.5.2.2. Market Attractiveness, By Country
11.5.5.3. Brazil Anti-infective Drugs Market
11.5.5.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.5.5.4. Mexico Anti-infective Drugs Market
11.5.5.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.5.5.5. Rest of Latin America Anti-infective Drugs Market
11.5.5.5.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

11.6. Middle East & Africa Anti-infective Drugs Market
11.6.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.6.2. By Product Type
11.6.2.1. Introduction
11.6.2.2. Strategic Insights
11.6.2.2.1. BPS Analysis, By Product Type
11.6.2.2.2. Market Attractiveness, By Product Type
11.6.2.3. Anti-bacterial Drugs
11.6.2.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.6.2.3.2. B-lactams
11.6.2.3.2.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.6.2.3.3. Quinolones
11.6.2.3.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.6.2.3.4. Macrolides
11.6.2.3.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.6.2.3.5. Tetracycline
11.6.2.3.5.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.6.2.3.6. Aminoglycoside
11.6.2.3.6.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.6.2.3.7. Others
11.6.2.3.7.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.6.2.4. Anti-fungal Drugs
11.6.2.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.6.2.4.2. Azoles
11.6.2.4.2.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.6.2.4.3. Echinocandins
11.6.2.4.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.6.2.4.4. Polyenes
11.6.2.4.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.6.2.5. Anti-viral Drugs
11.6.2.5.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.6.3. By Indication
11.6.3.1. Introduction
11.6.3.2. Strategic Insights
11.6.3.2.1. BPS Analysis, By Indication
11.6.3.2.2. Market Attractiveness, By Indication
11.6.3.3. Pneumonia
11.6.3.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.6.3.4. Methicillin-resistant Staphylococcus Aureus (MRSA)
11.6.3.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.6.3.5. Sepsis
11.6.3.5.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.6.3.6. Tuberculosis
11.6.3.6.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.6.3.7. Dermatophytosis
11.6.3.7.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.6.3.8. Aspergillosis
11.6.3.8.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.6.3.9. Candidiasis
11.6.3.9.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.6.3.10. Hepatitis Virus Infection
11.6.3.10.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.6.3.11. HIV Infection
11.6.3.11.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.6.3.12. Respiratory Virus Infection
11.6.3.12.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.6.4. By Distribution Channel
11.6.4.1. Introduction
11.6.4.2. Strategic Insights
11.6.4.2.1. BPS Analysis, By Distribution Channel
11.6.4.2.2. Market Attractiveness, By Distribution Channel
11.6.4.3. Hospital Pharmacy
11.6.4.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.6.4.4. Retail Pharmacy
11.6.4.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.6.4.5. Online Sales
11.6.4.5.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.6.5. By Geography
11.6.5.1. Introduction
11.6.5.2. Strategic Insights
11.6.5.2.1. BPS Analysis, By Geography
11.6.5.2.2. Market Attractiveness, By Geography
11.6.5.3. GCC Anti-infective Drugs Market
11.6.5.3.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.6.5.4. North Africa Anti-infective Drugs Market
11.6.5.4.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.6.5.5. South Africa Anti-infective Drugs Market
11.6.5.5.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024
11.6.5.6. Rest of Middle East & Africa Anti-infective Drugs Market
11.6.5.6.1. Market Value and Forecast 2018-2024 & Y-o-Y Growth Analysis, 2019-2024

12. Competitive Landscape
12.1. Market Share of Key Players in Anti-infective Drugs Market
12.2. Anti-infective Drugs Company Analysis
12.2.1. Gilead Sciences
12.2.1.1. Company Overview
12.2.1.2. Product Offered
12.2.1.3. Business Strategy
12.2.1.4. Financials
12.2.1.5. SWOT Analysis
12.2.1.6. Market Share Analysis
12.2.1.7. Key Achievements & Developments
12.2.2. GlaxoSmithKline plc
12.2.3. Merck & Co
12.2.4. Teva Pharmaceutical Industries Ltd.
12.2.5. Johnson & Johnson
12.2.6. Boehringer Ingelheim GmbH
12.2.7. Pfizer
12.2.8. Mylan N.V.
12.2.9. Bristol-Myers Squibb
12.2.10. F. Hoffmann-La Roche Ltd
12.2.11. Other Major & Niche Players

13. Disclaimer

Request For Customization



Request Customization

Check Discount



Request Discount